| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 28, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 53,800 | $1.49 | $80,162.00 | +0.5% | |
| Feb 28, 2022 | Lee Willis C | Vice Chairman &COO | Buy | 21,100 | $1.49 | $31,463.00 | +2.1% | |
| Feb 25, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 16,500 | $1.42 | $23,485.00 | - | |
| Feb 22, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 19,300 | $1.44 | $27,777.00 | - | |
| Feb 17, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 7,500 | $1.44 | $10,765.00 | - | |
| Feb 15, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 12,000 | $1.45 | $17,400.00 | - | |
| Feb 11, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 30,500 | $1.46 | $44,385.00 | - | |
| Feb 8, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 8,500 | $1.48 | $12,560.00 | - | |
| Feb 4, 2022 | Niihara Yutaka | Chairman And CEO | Buy | 13,250 | $1.42 | $18,760.00 | - | |
| Jan 3, 2022 | Lui Alfred Fu Kong | Director | Buy | 10,000 | $1.58 | $15,800.00 | New |